A genotype-first approach to defining the subtypes of a complex disease

Holly Stessman, Raphael Bernier, Evan E. Eichler

Research output: Contribution to journalReview article

104 Citations (Scopus)

Abstract

Medical genetics typically entails the detailed characterization of a patient's phenotypes followed by genotyping to discover the responsible gene or mutation. Here, we propose that the systematic discovery of genetic variants associated with complex diseases such as autism are progressing to a point where a reverse strategy may be fruitful in assigning the pathogenic effects of many different genes and in determining whether particular genotypes manifest as clinically recognizable phenotypes. This "genotype-first" approach for complex disease necessitates the development of large, highly integrated networks of researchers, clinicians, and patient families, with the promise of improved therapies for subsets of patients.

Original languageEnglish (US)
Pages (from-to)872-877
Number of pages6
JournalCell
Volume156
Issue number5
DOIs
StatePublished - Feb 27 2014
Externally publishedYes

Fingerprint

Genes
Genotype
Phenotype
Medical Genetics
Autistic Disorder
Research Personnel
Mutation
Therapeutics
Genetics

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

A genotype-first approach to defining the subtypes of a complex disease. / Stessman, Holly; Bernier, Raphael; Eichler, Evan E.

In: Cell, Vol. 156, No. 5, 27.02.2014, p. 872-877.

Research output: Contribution to journalReview article

Stessman, Holly ; Bernier, Raphael ; Eichler, Evan E. / A genotype-first approach to defining the subtypes of a complex disease. In: Cell. 2014 ; Vol. 156, No. 5. pp. 872-877.
@article{0dde30c4c2af458a9488c07246d7b706,
title = "A genotype-first approach to defining the subtypes of a complex disease",
abstract = "Medical genetics typically entails the detailed characterization of a patient's phenotypes followed by genotyping to discover the responsible gene or mutation. Here, we propose that the systematic discovery of genetic variants associated with complex diseases such as autism are progressing to a point where a reverse strategy may be fruitful in assigning the pathogenic effects of many different genes and in determining whether particular genotypes manifest as clinically recognizable phenotypes. This {"}genotype-first{"} approach for complex disease necessitates the development of large, highly integrated networks of researchers, clinicians, and patient families, with the promise of improved therapies for subsets of patients.",
author = "Holly Stessman and Raphael Bernier and Eichler, {Evan E.}",
year = "2014",
month = "2",
day = "27",
doi = "10.1016/j.cell.2014.02.002",
language = "English (US)",
volume = "156",
pages = "872--877",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - A genotype-first approach to defining the subtypes of a complex disease

AU - Stessman, Holly

AU - Bernier, Raphael

AU - Eichler, Evan E.

PY - 2014/2/27

Y1 - 2014/2/27

N2 - Medical genetics typically entails the detailed characterization of a patient's phenotypes followed by genotyping to discover the responsible gene or mutation. Here, we propose that the systematic discovery of genetic variants associated with complex diseases such as autism are progressing to a point where a reverse strategy may be fruitful in assigning the pathogenic effects of many different genes and in determining whether particular genotypes manifest as clinically recognizable phenotypes. This "genotype-first" approach for complex disease necessitates the development of large, highly integrated networks of researchers, clinicians, and patient families, with the promise of improved therapies for subsets of patients.

AB - Medical genetics typically entails the detailed characterization of a patient's phenotypes followed by genotyping to discover the responsible gene or mutation. Here, we propose that the systematic discovery of genetic variants associated with complex diseases such as autism are progressing to a point where a reverse strategy may be fruitful in assigning the pathogenic effects of many different genes and in determining whether particular genotypes manifest as clinically recognizable phenotypes. This "genotype-first" approach for complex disease necessitates the development of large, highly integrated networks of researchers, clinicians, and patient families, with the promise of improved therapies for subsets of patients.

UR - http://www.scopus.com/inward/record.url?scp=84896829795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896829795&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2014.02.002

DO - 10.1016/j.cell.2014.02.002

M3 - Review article

C2 - 24581488

AN - SCOPUS:84896829795

VL - 156

SP - 872

EP - 877

JO - Cell

JF - Cell

SN - 0092-8674

IS - 5

ER -